NCT06765655
Perioperative Glucose Monitoring and Treatment to Reduce Risk of Surgical Site Infections and Complications
Enrolling by Invitation
NAAges 18+InterventionalPreventionSt. Peter's Hospital, Albany, NYInvestigator-initiated
~266 participants
Updated 2025-01-09 on ClinicalTrials.gov
What's tested:Insulin Lispro Injectionglucose testing
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Surgical Site Infections
Measured over From date of surgery to the end of 30 day postop timeframe
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Jamila Benmoussa, MD · STUDY_DIRECTOR · St. Peter's Hospital
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Surgical Site InfectionsFrom date of surgery to the end of 30 day postop timeframe
Assess for the development of superficial, deep, or organ space infections within 30 days of surgery